"When Im talking to patients about going on these drugs, theyre like, I don't want to go on another medicine. I go, You know what
Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming
GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGF1/Smad-Mediated Epithelial-to-Mesenchymal Transition
It is not approved for human consumption, therapeutic use, or medical diagnosis
Because tirzepatide targets two incretin receptors rather than one, its weight loss trajectory tends to be steeper initially, with greater total weight loss over time compared to semaglutide monotherapy